cancer biosimilars

Views & Analysis

Adrian van den Hoven of Medicines for Europe addresses three big questions facing the biosmilars sector in Europe in 2018.

News

Moderna saw its Q1 sales nearly triple to $389m, almost a threefold rise on the same period of 2025, with international markets driving the increase.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.